Abstract
Dysregulation of pleiotropic growth factors, receptors and their downstream signaling pathway components represent a central protumorigenic principle in human hepatocarcinogenesis. Especially the Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/β-catenin/FZD), Transforming Growth Factor α/Epidermal Growth Factor receptor (TGFα/EGFR) and Transforming Growth Factor β (TGFβ/TβR) pathways contribute to proliferation, antiapoptosis and invasive behavior of tumor cells. This review focuses on the relevant alterations in these pathways identified in human human hepatocellular carcinomas (HCCs). Resultant functional effects are modulated by multiple cross-talks between the different signaling pathways and additional tumor-relevant factors, such as cyclooxygenase-2 and p53. Several specific strategies are currently under development such as receptor kinase inhibitors, neutralizing antibodies and antagonistic proteins, which may improve the systemic treatment of human HCCs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M et al. (2002). Hepatology 35: 1117–1124.
Abou-Shady M, Baer HU, Friess H, Berberat P, Zimmermann A, Graber H et al. (1999). Am J Surg 177: 209–215.
Adachi Y, Lee CT, Coffee K, Yamagata N, Ohm JE, Park KH et al. (2002). Gastroenterology 123: 1191–1204.
Aihara T, Noguchi S, Sasaki Y, Nakano H, Monden M, Imaoka S . (1996). Gastroenterology 111: 455–461.
Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M et al. (2003). Cancer Res 63: 728–734.
Arteaga C . (2003). Semin Oncol 30: 3–14.
Arteaga CL . (2001). J Clin Oncol 19: 32S–40S.
Arteaga CL, Osborne CK . (1989). Cancer Res 49: 6237–6241.
Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG et al. (2001). Clin Cancer Res 7: 1410–1418.
Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL . (2002). J Cell Sci 115: 3193–3206.
Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL . (2000). J Biol Chem 275: 36803–36810.
Baselga J, Averbuch SD . (2000). Drugs 60 (Suppl 1): 33–40 (discussion 41–42).
Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B . (1997). Biochim Biophys Acta 1332: F105–F126.
Bedossa P, Peltier E, Terris B, Franco D, Poynard T . (1995). Hepatology 21: 760–766.
Behrens J, Lustig B . (2004). Int J Dev Biol 48: 477–487.
Berthou S, Aebersold DM, Schmidt LS, Stroka D, Heigl C, Streit B et al. (2004). Oncogene 23: 5387–5393.
Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME et al. (2001). Mol Biol Cell 12: 27–36.
Blum G, Gazit A, Levitzki A . (2000). Biochemistry 39: 15705–15712.
Blum G, Gazit A, Levitzki A . (2003). J Biol Chem 278: 40442–40454.
Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM et al. (2003). J Biol Chem 278: 15991–15997.
Boissan M, Beurel E, Wendum D, Rey C, Lecluse Y, Housset C et al. (2005). Am J Pathol 167: 869–877.
Boix L, Rosa JL, Ventura F, Castells A, Bruix J, Rodes J et al. (1994). Hepatology 19: 88–91.
Boon EM, Keller JJ, Wormhoudt TA, Giardiello FM, Offerhaus GJ, van der Neut R et al. (2004). Br J Cancer 90: 224–229.
Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C . (2004). Proc Natl Acad Sci U S A 101: 10608–10613.
Braulke T . (1999). Horm Metab Res 31: 242–246.
Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P et al. (2004). Cancer Res 64: 6058–6064.
Brodt P, Fallavollita L, Khatib AM, Samani AA, Zhang D . (2001). J Biol Chem 276: 33608–33615.
Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR et al. (1995). Nature 377: 646–649.
Byrd JC, Devi GR, de Souza AT, Jirtle RL, MacDonald RG . (1999). J Biol Chem 274: 24408–24416.
Cagatay T, Ozturk M . (2002). Oncogene 21: 7971–7980.
Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D et al. (1988). Cancer Res 48: 6844–6849.
Chang L, Karin M . (2001). Nature 410: 37–40.
Chen BH, Xie Q, Liu KD . (2003). Zhonghua Gan Zang Bing Za Zhi 11: 487–489.
Chen JH, Wu CW, Kao HL, Chang HM, Li AF, Liu TY et al. (2005). Cancer Lett (in press).
Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M . (1997). Nature 389: 85–89.
Cheng PL, Chang MH, Chao CH, Lee YH . (2004). Oncogene 23: 7821–7838.
Christensen JG, Burrows J, Salgia R . (2005). Cancer Lett 225: 1–26.
Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, Le P et al. (2003). Cancer Res 63: 7345–7355.
Chuang LY, Tsai JH, Yeh YC, Chang CC, Yeh HW, Guh JY et al. (1991). Hepatology 13: 1112–1116.
Civenni G, Holbro T, Hynes NE . (2003). EMBO Rep 4: 166–171.
Cohen BD, Baker DA, Soderstrom C, Tkalcevic G, Rossi AM, Miller PE et al. (2005). Clin Cancer Res 11: 2063–2073.
Cui J, Zhou X, Liu Y, Tang Z, Romeih M . (2003). J Gastroenterol Hepatol 18: 280–287.
D’Errico A, Fiorentino M, Ponzetto A, Daikuhara Y, Tsubouchi H, Brechot C et al. (1996). Hepatology 24: 60–64.
DaCosta Byfield S, Major C, Laping NJ, Roberts AB . (2004). Mol Pharmacol 65: 744–752.
Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y et al. (2003). Mol Carcinogen 36: 130–141.
de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O et al. (1998). Proc Natl Acad Sci U S A 95: 8847–8851.
De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S . (1998). Cancer Res 58: 2234–2239.
De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL . (1995a). Oncogene 10: 1725–1729.
De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL . (1995b). Nat Genet 11: 447–449.
Derynck R, Zhang YE . (2003). Nature 425: 577–584.
Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, London SJ et al. (2001). Mol Carcinogen 31: 68–73.
Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG . (1999). Cancer Res 59: 4314–4319.
Di Popolo A, Memoli A, Apicella A, Tuccillo C, di Palma A, Ricchi P et al. (2000). Oncogene 19: 5517–5524.
Efimova EA, Glanemann M, Liu L, Schumacher G, Settmacher U, Jonas S et al. (2004). Eur Surg Res 36: 300–307.
El-Serag HB . (2002). J Clin Gastroenterol 35: S72–S78.
Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M et al. (2004). Proc Natl Acad Sci U S A 101: 12682–12687.
Enomoto A, Esumi M, Yamashita K, Takagi K, Takano S, Iwai S . (2001). J Pathol 195: 349–354.
Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D . (1997). Endocrinology 138: 2979–2988.
Fan G, Ma X, Wong PY, Rodrigues CM, Steer CJ . (2004). Apoptosis 9: 211–221.
Feng XH, Zhang Y, Wu RY, Derynck R . (1998). Genes Dev 12: 2153–2163.
Ficari F, Cama A, Valanzano R, Curia MC, Palmirotta R, Aceto G et al. (2000). Br J Cancer 82: 348–353.
Firth SM, Baxter RC . (2002). Endocr Rev 23: 824–854.
Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM . (2000). Oncogene 19: 3041–3049.
Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C et al. (2005). J Pathol 205: 145–153.
Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A et al. (1999). Mol Cell Biol 19: 3278–3288.
Fujito T, Sasaki Y, Iwao K, Miyoshi Y, Yamada T, Ohigashi H et al. (2004). Hepatogastroenterology 51: 921–924.
Garcia-Echeverria C, Pearson MA, Marti A, Meyer T, Mestan J, Zimmermann J et al. (2004). Cancer Cell 5: 231–239.
Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S . (2005). Gastroenterology 129: 1375–1383.
Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M . (2004). Cancer Res 64: 236–242.
Gong Y, Cui L, Minuk GY . (2000). Mol Cell Biochem 207: 101–104.
Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R et al. (2002). J Cell Sci 115: 1189–1202.
Goya M, Miyamoto S, Nagai K, Ohki Y, Nakamura K, Shitara K et al. (2004). Cancer Res 64: 6252–6258.
Grasl-Kraupp B, Schausberger E, Hufnagl K, Gerner C, Low-Baselli A, Rossmanith W et al. (2002). Hepatology 35: 1372–1380.
Gray SG, Kytola S, Lui WO, Larsson C, Ekstrom TJ . (2000). Int J Mol Med 5: 33–41.
Gronborg M, Wulff BS, Rasmussen JS, Kjeldsen T, Gammeltoft S . (1993). J Biol Chem 268: 23435–23440.
Guirouilh J, Castroviejo M, Balabaud C, Desmouliere A, Rosenbaum J . (2000). Int J Oncol 17: 777–781.
Guirouilh J, Le Bail B, Boussarie L, Balabaud C, Bioulac-Sage P, Desmouliere A et al. (2001). J Hepatol 34: 78–83.
Guo L, Kozlosky CJ, Ericsson LH, Daniel TO, Cerretti DP, Johnson RS . (2003). J Am Soc Mass Spectrom 14: 1022–1031.
Hailey J, Maxwell E, Koukouras K, Bishop WR, Pachter JA, Wang Y . (2002). Mol Cancer Ther 1: 1349–1353.
Halder SK, Beauchamp RD, Datta PK . (2005). Neoplasia 7: 509–521.
Han C, Michalopoulos GK, Wu T . (2006). J Cell Physiol 207: 261–270.
Harries M, Smith I . (2002). Endocr Relat Cancer 9: 75–85.
Harris TM, Rogler LE, Rogler CE . (1998). Oncogene 16: 203–209.
Hayashi T, Hideshima T, Nguyen AN, Munoz O, Podar K, Hamasaki M et al. (2004). Clin Cancer Res 10: 7540–7546.
Heideman DA, Overmeer RM, van Beusechem VW, Lamers WH, Hakvoort TB, Snijders PJ et al. (2005). Cancer Gene Ther 12: 954–962.
Hisaka T, Yano H, Haramaki M, Utsunomiya I, Kojiro M . (1999). Int J Oncol 14: 453–460.
Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ et al. (2004). Mol Cancer Ther 3: 737–745.
Hopfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherubl H . (2004). J Hepatol 41: 1008–1016.
Hov H, Holt RU, Ro TB, Fagerli UM, Hjorth-Hansen H, Baykov V et al. (2004). Clin Cancer Res 10: 6686–6694.
Hsia CC, Axiotis CA, Di Bisceglie AM, Tabor E . (1992). Cancer 70: 1049–1056.
Hsieh SY, Hsieh PS, Chiu CT, Chen WY . (2004). Oncogene 23: 9183–9189.
Hsu C, Huang CL, Hsu HC, Lee PH, Wang SJ, Cheng AL . (2002). Cancer 94: 415–420.
Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY . (2000). Am J Pathol 157: 763–770.
Huang SS, Huang JS . (2005). J Cell Biochem 96: 447–462.
Huether A, Hopfner M, Baradari V, Schuppan D, Scherubl H . (2005a). Biochem Pharmacol 70: 1568–1578.
Huether A, Hopfner M, Sutter AP, Schuppan D, Scherubl H . (2005b). J Hepatol 43: 661–669.
Huynh H, Chow PK, Ooi LL, Soo KC . (2002). Cell Growth Differ 13: 115–122.
Idobe Y, Murawaki Y, Kitamura Y, Kawasaki H . (2003). Hepatogastroenterology 50: 54–59.
Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J et al. (2002). Clin Cancer Res 8: 450–456.
Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD et al. (2002). Mol Pharmacol 62: 65–74.
Inui Y, Higashiyama S, Kawata S, Tamura S, Miyagawa J, Taniguchi N et al. (1994). Gastroenterology 107: 1799–1804.
Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T et al. (2004). Int J Oncol 24: 1077–1083.
Ito Y, Takeda T, Higashiyama S, Sakon M, Wakasa KI, Tsujimoto M et al. (2001a). Oncol Rep 8: 903–907.
Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K et al. (2001b). Br J Cancer 84: 1377–1383.
Jacobs S, Cook S, Svoboda ME, Van Wyk JJ . (1986). Endocrinology 118: 223–226.
Jiang Y, Xu W, Lu J, He F, Yang X . (2001). Biochem Biophys Res Commun 286: 1123–1130.
Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC . (2000). J Biol Chem 275: 8806–8811.
Johnson M, Kochhar K, Nakamura T, Iyer A . (1995). Biochem Mol Biol Int 36: 465–474.
Johnson M, Koukoulis G, Matsumoto K, Nakamura T, Iyer A . (1993). Hepatology 17: 1052–1061.
Jones JI, Clemmons DR . (1995). Endocr Rev 16: 3–34.
Joo M, Lee HK, Kang YK . (2003). J Korean Med Sci 18: 211–217.
Kang-Park S, Lee JH, Shin JH, Lee YI . (2001). Biochem Biophys Res Commun 283: 303–307.
Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D . (1993). J Biol Chem 268: 2655–2661.
Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. (2000). Mol Cell 6: 1365–1375.
Kern MA, Schoneweiss MM, Sahi D, Bahlo M, Haugg AM, Kasper HU et al. (2004). Carcinogenesis 25: 1193–1199.
Kern MA, Schubert D, Sahi D, Schoneweiss MM, Moll I, Haugg AM et al. (2002). Hepatology 36: 885–894.
Kikuchi A . (2003). Cancer Sci 94: 225–229.
Kim HG, Chung YH, Song BC, Kim J, Yang SH, Lee YS et al. (2000). Korean J Intern Med 15: 165–170.
Kim JH, Rho HM . (2002). Mol Cell Biochem 231: 155–161.
Kim SO, Park JG, Lee YI . (1996). Cancer Res 56: 3831–3836.
Kira S, Nakanishi T, Suemori S, Kitamoto M, Watanabe Y, Kajiyama G . (1997). Liver 17: 177–182.
Kiss A, Wang NJ, Xie JP, Thorgeirsson SS . (1997). Clin Cancer Res 3: 1059–1066.
Kretzschmar M, Doody J, Timokhina I, Massague J . (1999). Genes Dev 13: 804–816.
Lafarge-Frayssinet C, Duc HT, Frayssinet C, Sarasin A, Anthony D, Guo Y et al. (1997). Cancer Gene Ther 4: 276–285.
Lee JT, McCubrey JA . (2003). Curr Opin Invest Drugs 4: 757–763.
Lee S, Park U, Lee YI . (2001). Virology 283: 167–177.
Lee YI, Han YJ, Lee SY, Park SK, Park YJ, Moon HB et al. (2003). Mol Cell Endocrinol 203: 51–63.
Lee YI, Lee S, Das GC, Park US, Park SM . (2000). Oncogene 19: 3717–3726.
Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD et al. (1998). Oncogene 16: 2367–2380.
Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F et al. (2004). Cancer Cell 5: 91–102.
Li X, Nong Z, Ekstrom C, Larsson E, Nordlinder H, Hofmann WJ et al. (1997). Cancer Res 57: 2048–2054.
Lipinski KS, Djeha HA, Gawn J, Cliffe S, Maitland NJ, Palmer DH et al. (2004). Mol Ther 10: 150–161.
Liu F, Pouponnot C, Massague J . (1997). Genes Dev 11: 3157–3167.
Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. (2001a). Mol Cell 7: 927–936.
Liu X, Sun Y, Weinberg RA, Lodish HF . (2001b). Cytokine Growth Factor Rev 12: 1–8.
Longerich T, Breuhahn K, Odenthal M, Petmecky K, Schirmacher P . (2004). Virchows Arch 445: 589–596.
Lund P, Schubert D, Niketeghad F, Schirmacher P . (2004). Cancer Lett 206: 85–96.
Martin DC, Fowlkes JL, Babic B, Khokha R . (1999). J Cell Biol 146: 881–892.
Massague J . (1998). Annu Rev Biochem 67: 753–791.
Massague J, Pandiella A . (1993). Annu Rev Biochem 62: 515–541.
Matsuo K, Satoh S, Okabe H, Nomura A, Maeda T, Yamaoka Y et al. (2003). Genes Chromosomes Cancer 36: 283–291.
Matsuzawa S, Takayama S, Froesch BA, Zapata JM, Reed JC . (1998). EMBO J 17: 2736–2747.
Matsuzawa SI, Reed JC . (2001). Mol Cell 7: 915–926.
McCawley LJ, O’Brien P, Hudson LG . (1998). J Cell Physiol 176: 255–265.
Mead JE, Fausto N . (1989). Proc Natl Acad Sci U S A 86: 1558–1562.
Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL et al. (2000). Anticancer Drug Des 15: 29–41.
Menu E, Jernberg Wiklund H, Stromberg T, De Raeve H, Girnita L, Larsson O et al. (2005). Blood 107: 655–660.
Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A et al. (2004). Gastroenterology 127: 1110–1122.
Mikami I, You L, He B, Xu Z, Batra S, Lee AY et al. (2005). BMC Cancer 5: 53.
Min Y, Adachi Y, Yamamoto H, Imsumran A, Arimura Y, Endo T et al. (2005). Gut 54: 591–600.
Min Y, Adachi Y, Yamamoto H, Ito H, Itoh F, Lee CT et al. (2003). Cancer Res 63: 6432–6441.
Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M et al. (2004). Cancer Cell 5: 221–230.
Miyamoto S, Nakamura M, Shitara K, Nakamura K, Ohki Y, Ishii G et al. (2005). Clin Cancer Res 11: 3494–3502.
Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y et al. (2004). Br J Cancer 90: 1265–1273.
Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S et al. (1998). Cancer Res 58: 2524–2527.
Mohan S, Baylink DJ . (2002). J Endocrinol 175: 19–31.
Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P . (2005). Br J Cancer 92: 935–941.
Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmouliere A, Rosenbaum J . (2002). Int J Cancer 97: 157–162.
Monvoisin A, Neaud V, De Ledinghen V, Dubuisson L, Balabaud C, Bioulac-Sage P et al. (1999). J Hepatol 30: 511–518.
Murphy LJ . (1998). J Mol Endocrinol 21: 97–107.
Musch A, Rabe C, Paik MD, Berna MJ, Schmitz V, Hoffmann P et al. (2005). Digestion 71: 78–91.
Musgrove EA . (2004). Breast Cancer Res 6: 65–68.
Nagata K, Hirono S, Ido A, Kataoka H, Moriuchi A, Shimomura T et al. (2001). Biochem Biophys Res Commun 289: 205–211.
Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R et al. (1997). Nature 389: 631–635.
Nakopoulou L, Stefanaki K, Filaktopoulos D, Giannopoulou I . (1994). Histol Histopathol 9: 677–682.
Nardone G, Romano M, Calabro A, Pedone PV, de Sio I, Persico M et al. (1996). Hepatology 23: 1304–1312.
Nath N, Kashfi K, Chen J, Rigas B . (2003). Proc Natl Acad Sci U S A 100: 12584–12589.
Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P et al. (1997). Hepatology 26: 1458–1466.
Ng IO, Lee JM, Srivastava G, Ng M . (1998). J Gastroenterol Hepatol 13: 152–157.
Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA . (1999). Am J Pathol 155: 703–710.
Nishiyama M, Wands JR . (1992). Biochem Biophys Res Commun 183: 280–285.
Noguchi O, Enomoto N, Ikeda T, Kobayashi F, Marumo F, Sato C . (1996). J Hepatol 24: 286–292.
Ohmichi M, Pang L, Ribon V, Gazit A, Levitzki A, Saltiel AR . (1993). Biochemistry 32: 4650–4658.
Oka Y, Waterland RA, Killian JK, Nolan CM, Jang HS, Tohara K et al. (2002). Hepatology 35: 1153–1163.
Okano J, Shiota G, Kawasaki H . (1999). Liver 19: 151–159.
Okumoto K, Hattori E, Tamura K, Kiso S, Watanabe H, Saito K et al. (2004). Liver Int 24: 21–28.
Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S et al. (2003). Hepatol Res 27: 289–301.
Pang R, Yuen J, Yuen MF, Lai CL, Lee TK, Man K et al. (2004). Oncogene 23: 4182–4186.
Park BC, Huh MH, Seo JH . (1995). J Hepatol 22: 286–294.
Park WS, Dong SM, Kim SY, Na EY, Shin MS, Pi JH et al. (1999). Cancer Res 59: 307–310.
Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C . (2004). Hepatogastroenterology 51: 396–400.
Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D . (1997). Endocrinology 138: 1427–1433.
Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S et al. (2002). Oncogene 21: 2309–2319.
Pautsch A, Zoephel A, Ahorn H, Spevak W, Hauptmann R, Nar H . (2001). Structure (Camb) 9: 955–965.
Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, Hermine O et al. (2005). Oncogene 24: 6119–6132.
Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM . (2003). Cancer Cell 3: 347–361.
Petritsch C, Beug H, Balmain A, Oft M . (2000). Genes Dev 14: 3093–3101.
Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G et al. (2005). J Clin Oncol 23: 6657–6663.
Polakis P . (2001). Cell 105: 563–566.
Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD et al. (1999). J Pharmacol Exp Ther 291: 739–748.
Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K et al. (2003). J Pathol 201: 250–259.
Prange W, Schirmacher P . (2001). Oncol Rep 8: 727–730.
Reiss K, D’Ambrosio C, Tu X, Tu C, Baserga R . (1998). Clin Cancer Res 4: 2647–2655.
Reiss K, Tu X, Romano G, Peruzzi F, Wang JY, Baserga R . (2001). Clin Cancer Res 7: 2134–2144.
Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C et al. (2001). Mol Biol Cell 12: 725–738.
Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R et al. (1995). Cancer Res 55: 2463–2469.
Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R et al. (1994). Cancer Res 54: 2218–2222.
Rusnak DW, Lackey K, Affleck K, Wood ER, Alligood KJ, Rhodes N et al. (2001). Mol Cancer Ther 1: 85–94.
Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP . (2001). Nat Cell Biol 3: 793–801.
Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D . (2003). Cancer Res 63: 627–635.
Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I et al. (2000). J Cell Biol 150: 1375–1384.
Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I et al. (2000). Cancer 88: 1025–1029.
Sakai K, Clemmons DR . (2003). Endocrinology 144: 2388–2395.
Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H . (1995). J Invest Dermatol 104: 958–963.
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). Nat Genet 24: 245–250.
Schausberger E, Hufnagl K, Parzefall W, Gerner C, Kandioler-Eckersberger D, Wrba F et al. (2004). Br J Cancer 91: 1955–1963.
Schirmacher P, Held WA, Yang D, Biempica L, Rogler CE . (1991). Am J Pathol 139: 231–241.
Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE . (1992). Cancer Res 52: 2549–2556.
Schirmacher P, Schauss D, Dienes HP . (1996). J Hepatol 24: 547–554.
Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M et al. (1995). Nature 373: 699–702.
Scotlandi K, Benini S, Nanni P, Lollini PL, Nicoletti G, Landuzzi L et al. (1998). Cancer Res 58: 4127–4131.
Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S et al. (2005). Cancer Res 65: 3868–3876.
Sedlaczek N, Hasilik A, Neuhaus P, Schuppan D, Herbst H . (2003). Br J Cancer 88: 733–739.
Selden C, Farnaud S, Ding SF, Habib N, Foster C, Hodgson HJ . (1994). J Hepatol 21: 227–234.
Seol DW, Chen Q, Zarnegar R . (2000). Oncogene 19: 1132–1137.
Sherr CJ, McCormick F . (2002). Cancer Cell 2: 103–112.
Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S . (2003). Hepatology 38: 178–186.
Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y et al. (1999). Hepatogastroenterology 46: 407–412.
Slichenmyer WJ, Elliott WL, Fry DW . (2001). Semin Oncol 28: 80–85.
Sohda T, Yun K, Iwata K, Soejima H, Okumura M . (1996). Lab Invest 75: 307–311.
Song BC, Chung YH, Kim JA, Choi WB, Suh DD, Pyo SI et al. (2002). Cancer 94: 175–180.
Spicer J . (2004). Curr Opin Mol Ther 6: 337–343.
Stuart KA, Riordan SM, Lidder S, Crostella L, Williams R, Skouteris GG . (2000). Int J Exp Pathol 81: 17–30.
Su HY, Hickford JG, Bickerstaffe R, Palmer BR . (1999). Dermatol Online J 5: 1.
Sue SR, Chari RS, Kong FM, Mills JJ, Fine RL, Jirtle RL et al. (1995). Ann Surg 222: 171–178.
Sugiura R, Kita A, Shimizu Y, Shuntoh H, Sio SO, Kuno T . (2003). Nature 424: 961–965.
Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ et al. (2002). J Biol Chem 277: 12838–12845.
Sussenbach JS, Steenbergh PH, Holthuizen P . (1992). Growth Regul 2: 1–9.
Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K . (2000). Hepatology 32: 796–802.
Suzuki K, Hayashi N, Yamada Y, Yoshihara H, Miyamoto Y, Ito Y et al. (1994). Hepatology 20: 1231–1236.
Sweeney C, Carraway III KL . (2004). Br J Cancer 90: 289–293.
Tabor E, Farshid M, Di Bisceglie A, Hsia CC . (1992). J Med Virol 37: 271–273.
Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S et al. (2005). Gastroenterology 129: 285–302.
Tanaka S, Takenaka K, Matsumata T, Mori R, Sugimachi K . (1996). Dig Dis Sci 41: 208–215.
Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM et al. (2002). Oncogene 21: 4863–4871.
Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S . (2000). Int J Cancer 87: 644–649.
Tojo M, Hamashima Y, Hanyu A, Kajimoto T, Saitoh M, Miyazono K et al. (2005). Cancer Sci 96: 791–800.
Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J . (1992). Proc Natl Acad Sci U S A 89: 4874–4878.
Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML . (1993). Science 259: 94–97.
Trusolino L, Bertotti A, Comoglio PM . (2001). Cell 107: 643–654.
Tsai JF, Chuang LY, Jeng JE, Yang ML, Chang WY, Hsieh MY et al. (1997). Medicine (Baltimore) 76: 213–226.
Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E . (1997). Hepatology 25: 619–623.
Ueno Y, Sakurai H, Matsuo M, Choo MK, Koizumi K, Saiki I . (2005). Br J Cancer 92: 1690–1695.
Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R et al. (2004). Cancer Res 64: 7954–7961.
Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O . (2004). Oncogene 23: 7854–7862.
Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y . (2004). J Gastroenterol 39: 1182–1188.
Vernucci M, Cerrato F, Besnard N, Casola S, Pedone PV, Bruni CB et al. (2000). Oncogene 19: 6376–6385.
Vu TH, Hoffman AR . (1994). Nature 371: 714–717.
Wada I, Kanada H, Nomura K, Kato Y, Machinami R, Kitagawa T . (1999). Hepatology 29: 1718–1721.
Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM . (2001). J Cell Biol 153: 1023–1034.
Wang SY, Chen B, Zhan YQ, Xu WX, Li CY, Yang RF et al. (2004). J Hepatol 41: 267–273.
Wang X, Le P, Liang C, Chan J, Kiewlich D, Miller T et al. (2003). Mol Cancer Ther 2: 1085–1092.
Warshamana-Greene GS, Litz J, Buchdunger E, Garcia-Echeverria C, Hofmann F, Krystal GW . (2005). Clin Cancer Res 11: 1563–1571.
Warshamana-Greene GS, Litz J, Buchdunger E, Hofmann F, Garcia-Echeverria C, Krystal GW . (2004). Mol Cancer Ther 3: 527–535.
Weihrauch M, Benick M, Lehner G, Wittekind M, Bader M, Wrbitzk R et al. (2001a). Int Arch Occup Environ Health 74: 405–410.
Weihrauch M, Benicke M, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A . (2001b). Br J Cancer 84: 982–989.
Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H et al. (2004). Cancer Res 64: 7099–7109.
Wirths O, Waha A, Weggen S, Schirmacher P, Kuhne T, Goodyer CG et al. (2003). Lab Invest 83: 429–434.
Wodarz A, Nusse R . (1998). Annu Rev Cell Dev Biol 14: 59–88.
Wong CM, Fan ST, Ng IO . (2001). Cancer 92: 136–145.
Wu T . (2006). Cancer Treat Rev 32: 28–44.
Xian ZH, Zhang SH, Cong WM, Wu WQ, Wu MC . (2005). J Clin Pathol 58: 500–503.
Xu Z, Shen MX, Ma DZ, Wang LY, Zha XL . (2003). Cell Res 13: 343–350.
Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M . (1999). Oncogene 18: 4879–4883.
Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T et al. (2002). Cancer 95: 824–834.
Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST et al. (2005). Oncogene 24: 1607–1614.
Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL et al. (1987). Cancer Res 47: 896–901.
Yuen MF, Norris S, Evans LW, Langley PG, Hughes RD . (2002). Scand J Gastroenterol 37: 233–238.
Zhang J, Wang WL, Li Q, Qiao Q . (2004). World J Gastroenterol 10: 830–833.
Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ et al. (1996). Cancer Res 56: 1367–1373.
Zhang T, Ma J, Cao X . (2003). Biochem J 376: 457–464.
Zhao M, Zimmermann A . (1998). Histol Histopathol 13: 657–670.
Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y et al. (2003). Cancer Lett 193: 161–170.
Zi X, Zhang J, Agarwal R, Pollak M . (2000). Cancer Res 60: 5617–5620.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breuhahn, K., Longerich, T. & Schirmacher, P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25, 3787–3800 (2006). https://doi.org/10.1038/sj.onc.1209556
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209556
Keywords
This article is cited by
-
Nonmetabolic role for CKB in ferroptosis
Nature Cell Biology (2023)
-
The role of YAP1 in liver cancer stem cells: proven and potential mechanisms
Biomarker Research (2022)
-
Insulin and the insulin receptor collaborate to promote human gastric cancer
Gastric Cancer (2022)
-
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Nature (2020)
-
Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells
Oncogene (2019)
